V
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G285.4 KBVerve Therapeutics, Inc.Nov 18, 5:23 PM ET·0000921895-24-002770
- SC 13G/A6.6 KBVerve Therapeutics, Inc.Nov 12, 5:52 PM ET·0000932471-24-001257
- SC 13G/A13.9 KBVerve Therapeutics, Inc.Nov 8, 2:17 PM ET·0002012383-24-003690
- 10-Q8.2 MBVerve Therapeutics, Inc.Nov 5, 7:30 AM ET·0000950170-24-121075
- 8-K328.8 KBVerve Therapeutics, Inc.Nov 5, 7:15 AM ET·0000950170-24-121072
- SC 13G/A5.6 KBVerve Therapeutics, Inc.Nov 4, 1:52 PM ET·0000932471-24-000689
- SC 13G/A13.9 KBVerve Therapeutics, Inc.Oct 22, 3:24 PM ET·0002012383-24-001272
- SC 13G55.9 KBVerve Therapeutics, Inc.Oct 16, 1:06 PM ET·0000093751-24-000772
- SC 13G/A95.6 KBVerve Therapeutics, Inc.Sep 9, 4:36 PM ET·0001273087-24-000089
- 10-Q8.3 MBVerve Therapeutics, Inc.Aug 8, 7:30 AM ET·0000950170-24-093327
Insiders
10- ADELMAN BURT ADirector
- Alphabet Inc.Member of 10% Group
- ARCH Venture Fund X, L.P.10% Owner
- ARCH Venture Partners X, LLC10% Owner
- Ashe Andrew D.See Remarks
- Beam Therapeutics Inc.10% Owner
- Beaudoin MargaretVice President, Finance
- Bellinger AndrewChief Scientific Officer
- Biomatics Capital Partners, L.P.10% Owner
- Broad Institute, Inc.10% Owner
Tickers
No tickers on record
Addresses
business
201 BROOKLINE AVENUE SUITE 601
BOSTON, MA, 02215
mailing
201 BROOKLINE AVENUE SUITE 601
BOSTON, MA, 02215